Information
-
Trademark
-
90572029
-
Serial Number
90572029
-
Registration Number
7166648
-
International Classifications
-
Filing Date
March 10, 2021
3 years ago
-
Registration Date
September 19, 2023
a year ago
-
Transaction Date
November 21, 2024
a month ago
-
Status Date
September 19, 2023
a year ago
-
Published for Opposition Date
April 25, 2023
a year ago
-
Location Date
September 19, 2023
a year ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
HUSSAIN, TASNEEM
-
Attorney Docket Number
537999
Attorney Name
ANDREW D. PRICE
Law Office Assigned Location Code
M90
-
Owners
Mark Drawing Code
4
Mark Identification
ARTY
Case File Statements
- GS0051: Pharmaceutical preparations for the treatment of cancer, viral infections, and tumorous diseases; biological preparations for the treatment of viral infections; biological preparations for medical use for the treatment of tumorous diseases; immunotherapeutic drugs, namely, pharmaceutical preparations for the treatment of cancer, viral infections, tumorous diseases; reagents for medical use; diagnostic preparations for medical purposes; diagnostic reagents for medical use; medical diagnostic reagents used in connection with drug discovery, namely, the identification of pharmaceutical targets and the development of molecules to be used for medicinal or therapeutic purposes; medical diagnostic reagents used in connection with protein engineering and biological drug development; all of the foregoing excluding treatment of osteoarticular disorders, of bone and joint pathologies, of musculoskeletal pathologies and of degenerative and chronic inflammatory pathologies, vertebral-spinal pathologies and disorders, degenerative and chronic inflammatory pathologies, inflammatory pathologies due to rheumatic disorders, or trauma or auto-immune conditions
- GS0421: Scientific and technological services, namely, pharmaceutical research and design relating thereto; pharmaceutical research and development services; pharmaceutical testing and clinical trials; research and development in the biotechnology field; drug discovery, namely, the identification of pharmaceutical targets and the development of molecules to be used for medicinal or therapeutic purposes; protein engineering and biological drug development; provision of information and consultancy in relation to the aforesaid services; all of the foregoing excluding treatment of osteoarticular disorders, of bone and joint pathologies, of musculoskeletal pathologies and of degenerative and chronic inflammatory pathologies, vertebral-spinal pathologies and disorders, degenerative and chronic inflammatory pathologies, inflammatory pathologies due to rheumatic disorders, or trauma or auto-immune conditions
Case File Event Statements
-
6/10/2021 - 3 years ago
3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
3/13/2021 - 3 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
3/29/2021 - 3 years ago
2 - TEAS VOLUNTARY AMENDMENT RECEIVED
Type: PARI
-
6/17/2021 - 3 years ago
4 - ASSIGNED TO LIE
Type: ALIE
-
6/24/2021 - 3 years ago
5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Type: AMPX
-
10/4/2021 - 3 years ago
6 - ASSIGNED TO EXAMINER
Type: DOCK
-
10/6/2021 - 3 years ago
7 - EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Type: CPEA
-
10/6/2021 - 3 years ago
8 - COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Type: EPEN
-
10/6/2021 - 3 years ago
9 - EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Type: GEAP
-
10/6/2021 - 3 years ago
10 - NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Type: GEAN
-
3/7/2022 - 2 years ago
11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
3/7/2022 - 2 years ago
12 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
3/7/2022 - 2 years ago
13 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
3/8/2022 - 2 years ago
14 - FINAL REFUSAL WRITTEN
Type: CNFR
-
3/8/2022 - 2 years ago
15 - FINAL REFUSAL E-MAILED
Type: GNFR
-
3/8/2022 - 2 years ago
16 - NOTIFICATION OF FINAL REFUSAL EMAILED
Type: GNFN
-
9/8/2022 - 2 years ago
17 - EXPARTE APPEAL RECEIVED AT TTAB
Type: EXAF
-
9/8/2022 - 2 years ago
18 - JURISDICTION RESTORED TO EXAMINING ATTORNEY
Type: JURT
-
9/8/2022 - 2 years ago
19 - EX PARTE APPEAL-INSTITUTED
Type: EXPI
-
9/8/2022 - 2 years ago
20 - TEAS REQUEST FOR RECONSIDERATION RECEIVED
Type: ERFR
-
9/16/2022 - 2 years ago
21 - SUSPENSION LETTER WRITTEN
Type: CNSL
-
9/16/2022 - 2 years ago
22 - LETTER OF SUSPENSION E-MAILED
Type: GNSL
-
9/16/2022 - 2 years ago
23 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Type: GNS3
-
12/28/2022 - 2 years ago
24 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Type: ASCK
-
3/16/2023 - a year ago
25 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
3/17/2023 - a year ago
26 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Type: ERRR
-
3/20/2023 - a year ago
27 - EXPARTE APPEAL TERMINATED
Type: EXPT
-
3/22/2023 - a year ago
28 - ELECTRONIC RECORD REVIEW COMPLETE
Type: FIXD
-
4/5/2023 - a year ago
29 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
4/25/2023 - a year ago
30 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
4/25/2023 - a year ago
31 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
6/20/2023 - a year ago
32 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
6/20/2023 - a year ago
35 - NOTICE OF ALLOWANCE CANCELLED
Type: IUCN
-
6/20/2023 - a year ago
33 - TEAS DELETE 1(B) BASIS RECEIVED
Type: D1BR
-
8/10/2023 - a year ago
36 - 1(B) BASIS DELETED; PROCEED TO REGISTRATION
Type: DP1B
-
8/10/2023 - a year ago
34 - CASE ASSIGNED TO INTENT TO USE PARALEGAL
Type: AITU
-
9/19/2023 - a year ago
38 - NOTICE OF REGISTRATION CONFIRMATION EMAILED
Type: NRCC
-
9/19/2023 - a year ago
37 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
11/20/2024 - a month ago
39 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Type: ASCK
